Chlamydia pneumoniae in HIV-infected patients and controls assessed by a novel whole blood interferon-γ assay, serology and PCR

Clinical Microbiology and Infection

Volumn 10, Issue 9, 2004, Pages 820-825

  Woolley, Ian J ^a   Larsen, M ^b   Jones, S ^c   Gahan, M E ^a   Jasenko, I ^c   Johnsen, S P ^d   Wesselingh, S ^a   Fuller, A ^a   Ostergaard, L ^b  

^a MONASH UNIVERSITY   (Australia)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c CSL LIMITED   (Australia)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Chlamydia pneumoniae; HIV; Interferon ; PCR; Serology

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ANTIBODY RESPONSE; ARTICLE; CARDIOVASCULAR DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOCOMPETENCE; MALE; MEDICAL ASSESSMENT; NONHUMAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; SEROLOGY; STATISTICAL SIGNIFICANCE;

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 4644371546     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1198-743X.2004.00952.x     Document Type: Article

References (31)

1. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451-461.
2. Cook PJ, Honeybourne D. Chlamydia pneumoniae. J Antimicrob Chemother 1994; 34: 859-873.
3. Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-986.
4. Larsen MM, Moern B, Fuller A, Andersen PL, Ostergaard LJ. Chlamydia pneumoniae and cardiovascular disease. Med J Aust 2002; 177: 558-562.
5. Danesh J, Whincup P, Lewington S et al. Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. Eur Heart J 2002; 23: 371-375.
6. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998; 31: 827-832.
7. Campbell LA, Rosenfeld M, Kuo CC. The role of Chlamydia pneumoniae in atherosclerosis - recent evidence from animal models. Trends Microbiol 2000; 8: 255-257.
8. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 1998; 177: 725-729.
9. Rottenberg ME, Gigliotti Rothfuchs A, Gigliotti D et al. Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. J Immunol 2000; 164: 4812-4818.
10. Halme S, von Hertzen L, Bloigu A et al. Chlamydia pneumoniae-specific cell-mediated and humoral immunity in healthy people. Scand J Immunol 1998; 47: 517-520.
11. Netea MG, Selzman CH, Kullberg BJ et al. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 2000; 30: 541-549.
12. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003; 348: 702-710.
13. Klein D, Hurley LB, Quesenberry CP, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J AIDS 2002; 30: 471-477.
14. Friis-Moller N, Sabin CA, Weber R et al. Data collection on adverse events of anti-HIV drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349: 1993-2003.
15. Mazurek GH, LoBue PA, Daley CL et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286: 1740-1747.
16. Knudsen K, Madsen AS, Mygind P, Christiansen G, Birkelund S. Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae. Infect Immun 1999; 67: 375-383.
17. Persson K, Boman J. Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae. Clin Diagn Lab Immunol 2000; 7: 739-744.
18. Johnsen S, Andersen PL, Stanek G et al. Chlamydia antibody response in healthy volunteers immunized with nonchlamydial antigens: a randomized, double-blind, placebo-controlled study. Clin Infect Dis 2003; 36: 586-591.
19. Storgaard M, Ostergaard L, Jensen JS et al. Chlamydia pneumoniae in children with otitis media. Clin Infect Dis 1997; 25: 1090-1093.
20. Birkebaek NH, Jensen JS, Seefeldt T et al. Chlamydia pneumoniae infection in adults with chronic cough compared with healthy blood donors. Eur Respir J 2000; 16: 108-111.
21. Hammerschlag MR. Diagnostic methods for intracellular pathogens. Clin Microbiol Infect 1996; 1(suppl 1): S3-S8.
22. Farholt S, Boman J, Gjoen K, Jensen JS, Ostergaard L. Chlamydia pneumoniae PCR: quality control is needed. In: Saikku P, ed. Proceedings of the 4th Meeting of the European Society for Chlamydia Research. Helsinki: Universitas Helsingiensis, 2000; 95.
23. Apfalter P, Assadian O, Blasi F et al. Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols. J Clin Microbiol 2002; 40: 4428-4434.
24. Galli G, Annunziato F, Cosmi L, Manetti R, Maggi E, Romagnani S. Th1 and th2 responses, HIV-1 coreceptors, and HIV-1 infection. J Biol Regul Homeost Agents 2001; 15: 308-313.
25. Pizzichini MM, Pizzichini E, Efthimiadis A et al. Markers of inflammation in induced sputum in acute bronchitis caused by Chlamydia pneumoniae. Thorax 1997; 52: 929-931.
26. Saikku P, Leinonen M, Tenkanen L et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273-278.
27. Cohen CR, Nguti R, Bukusi EA et al. Human immunodeficiency virus type 1-infected women exhibit reduced interferon-gamma secretion after Chlamydia trachomatis stimulation of peripheral blood lymphocytes. J Infect Dis 2000; 182: 1672-1673.
28. Halme S, Syrjala H, Bloigu A et al. Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease. Eur Heart J 1997; 18: 1095-1101.
29. de Boer OJ, van der Wal AC, Houtkamp MA, Ossewaarde JM, Teeling P, Becker AE. Unstable atherosclerotic plaques contain T-cells that respond to Chlamydia pneumoniae. Cardiovasc Res 2000; 48: 402-408.
30. Yip HC, Karulin AY, Tary-Lehmann M et al. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol 1999; 162: 3942-3949.
31. Swain SL. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1994; 1: 543-552.